Merck

Merck (MRK) Revenue Growth Comparison With Industry Growth From 2012 To 2016

This report provides a comparison of Merck & Co., Inc. (MRK) revenue growth with Pharmaceuticals industry growth during the last five years from 2012 to 2016. Merck reported a revenue growth of 0.8% year-over-year during 2016. The Pharmaceuticals industry growth was 7.7% year-over-year during 2016. Merck growth was slower than the industry during 2016.

Merck (MRK) Net Profit Margin Comparison With Industry From 2012 To 2016

This report provides a comparison of Merck & Co., Inc. (MRK) net profit margin with Pharmaceuticals industry net profit margin during the last five years from 2012 to 2016. Merck reported a net profit margin of 9.8% during 2016. The Pharmaceuticals industry net profit margin was 15.8% during 2016. Merck was less profitable than the industry during 2016.

Merck (MRK) Intangible Assets Analysis From 2012 To 2016

This report provides the last five years Intangible assets analysis of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck invested a total of $35.5 billion on Intangible assets during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck invested 89.1% of its total revenues on intangible assets during 2016. The Intangible asset numbers are for the fiscal year ending in December.

Merck (MRK) Accounts Payable (A/P) Analysis From 2012 To 2016

This report provides the last five years Accounts Payable (A/P) analysis of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck invested a total of $4.1 billion on accounts payable during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck invested 10.4% of its total revenues on accounts payable activities during 2016. The accounts payable numbers are for the fiscal year ending in December.

Merck (MRK) Sales, Marketing, General & Administrative (SG&A) Spending Analysis From 2012 To 2016

This report provides the last five years sales, marketing, general & administrative (SG&A) expenses of Merck & Co., Inc. (MRK) from 2012 to 2016. Merck spent a total of $9.8 billion on sales, marketing, general, and administrative (SG&A) activities during 2016. Merck generated a total of $39.8 billion revenues during 2016. As a percentage of revenues, Merck spent 24.5% of its total revenues on SG&A activities during 2016. The SG&A spending numbers are for the fiscal year ending in December.

How Merck Makes Money? Understanding Merck Business Model

This article is about how Merck & Co. makes money. Firstly, we explain the current (Rx Business model) and evolvingĀ business model (Beyond the pill...